Carl Zeiss Meditec AG
XETRA:AFX

Watchlist Manager
Carl Zeiss Meditec AG Logo
Carl Zeiss Meditec AG
XETRA:AFX
Watchlist
Price: 59.9 EUR -0.08%
Market Cap: 5.4B EUR
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one AFX stock under the Base Case scenario is 99.28 EUR. Compared to the current market price of 59.9 EUR, Carl Zeiss Meditec AG is Undervalued by 40%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

AFX Relative Value
Base Case
99.28 EUR
Undervaluation 40%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

2.5
P/S
P/S
Price to Sales
2.5
vs History
90
vs Industry
38
Median 3Y
4.3
Median 5Y
5.3
Industry
2.2
Forward
2.4
More Details
33.4
P/E
P/E
Price to Earnings
33.4
vs History
68
vs Industry
14
Median 3Y
33.4
Median 5Y
40.2
Industry
21.9
Forward
30.8
More Details
21.2
P/OCF
P/OCF
Price to OCF
21.2
vs History
52
vs Industry
15
Median 3Y
-138.4
Median 5Y
21.3
Industry
13.5
More Details
11.3
P/FCFE
P/FCFE
Price to FCFE
11.3
vs History
42
vs Industry
29
Median 3Y
-139.7
Median 5Y
10.7
Industry
19.3
More Details
2.6
P/B
P/B
Price to Book Value
2.6
vs History
90
vs Industry
29
Median 3Y
4.2
Median 5Y
5.4
Industry
2.1
More Details
2.8
EV/S
EV/S
Enterprise Value to Sales
2.8
vs History
90
vs Industry
35
Median 3Y
4.4
Median 5Y
5.4
Industry
2.3
Forward
2.6
More Details
5.3
EV/GP
EV/GP
Enterprise Value to Gross Profit
5.3
vs History
88
vs Industry
37
Median 3Y
7.8
Median 5Y
9.4
Industry
4.8
More Details
18.6
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
18.6
vs History
90
vs Industry
16
Median 3Y
25.4
Median 5Y
27.8
Industry
11.5
Forward
14.9
More Details
32.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
32.4
vs History
39
vs Industry
11
Median 3Y
28.4
Median 5Y
31.1
Industry
15.6
Forward
22.8
More Details
23.4
EV/OCF
EV/OCF
Enterprise Value to OCF
23.4
vs History
52
vs Industry
14
Median 3Y
-140.6
Median 5Y
23.5
Industry
13.3
More Details
60.9
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
60.9
vs History
25
vs Industry
6
Median 3Y
-142.6
Median 5Y
48.6
Industry
17.3
More Details
1.8
EV/IC
EV/IC
Enterprise Value to IC
1.8
vs History
90
vs Industry
36
Median 3Y
3.4
Median 5Y
4.2
Industry
1.8
More Details

Multiples Across Competitors

AFX Competitors Multiples
Carl Zeiss Meditec AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
DE
Carl Zeiss Meditec AG
XETRA:AFX
5.2B EUR 2.5 33.4 18.6 32.4
US
Abbott Laboratories
NYSE:ABT
230.4B USD 5.4 17.1 22.2 31.8
US
Intuitive Surgical Inc
NASDAQ:ISRG
188.9B USD 21.7 76.3 60.9 73.3
US
Boston Scientific Corp
NYSE:BSX
153.5B USD 8.7 75.5 35.6 49.4
US
Stryker Corp
NYSE:SYK
144.3B USD 6.2 50.5 25 30.1
IE
Medtronic PLC
NYSE:MDT
105.6B USD 3.2 24.8 13.3 18.8
DE
Siemens Healthineers AG
XETRA:SHL
53B EUR 2.3 26.7 15.4 22
US
Becton Dickinson and Co
NYSE:BDX
47.3B USD 2.3 31.2 12.6 23.6
US
Edwards Lifesciences Corp
NYSE:EW
44.1B USD 8 10.5 24.1 26.5
US
IDEXX Laboratories Inc
NASDAQ:IDXX
38.2B USD 9.7 42.7 30.4 33.9
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
267B CNY 7.5 24 20.9 20.9

See Also

Summary
AFX intrinsic value, competitors valuation, and company profile.
DCF Valuation
AFX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AFX stock valuation using valuation multiples.
Wall Street Estimates
AFX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AFX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 253,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.